Photodynamic therapy for unresectable cholangiocarcinoma

Digestive Diseases and Sciences

Volumn 57, Issue 2, 2012, Pages 274-283

  Tomizawa, Yutaka ^a   Tian, Jianmin ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Biliary tract cancer; Cholangiocarcinoma; Endoprostheses; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN;

ADJUVANT THERAPY; BILE DUCT CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER STAGING; ENDOPROSTHESIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; METASTASIS; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; STENT; SUNBURN; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TUMOR NECROSIS;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CHOLANGIOCARCINOMA; DIHEMATOPORPHYRIN ETHER; HUMANS; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; STENTS; TREATMENT OUTCOME;

EID: 84856692201     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1957-7     Document Type: Review

References (48)

1. Y Shaib HB El-Serag 2004 The epidemiology of cholangiocarcinoma Semin Liver Dis 24 115 125 15192785 10.1055/s-2004-828889 (Pubitemid 38738341)
2. KN Lazaridis GJ Gores 2005 Cholangiocarcinoma Gastroenterology 128 1655 1667 15887157 10.1053/j.gastro.2005.03.040 (Pubitemid 40692558)
3. EG Fritcher BR Kipp KC Halling, et al. 2009 A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures Gastroenterology 136 2180 2186 19232347 10.1053/j.gastro.2009.02.040
4. B Blechacz GJ Gores 2008 Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 308 321 18536057 10.1002/hep.22310 1:CAS:528:DC%2BD1cXptFemu70%3D (Pubitemid 351975555)
5. H Lang GC Sotiropoulos G Sgourakis, et al. 2009 Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients J Am Coll Surg 208 218 228 19228533 10.1016/j.jamcollsurg.2008.10.017
6. A Saiura J Yamamoto N Kokudo, et al. 2011 Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections Am J Surg 201 203 208 19427630 10.1016/j.amjsurg.2008.12. 035
7. K Shimada T Sano Y Sakamoto, et al. 2007 Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases J Surg Oncol 96 160 165 17443744 10.1002/jso.20792 (Pubitemid 47264820)
8. H Lang GC Sotiropoulos NR Frühauf, et al. 2005 Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period Ann Surg 241 134 143 15622001 (Pubitemid 40041002)
9. SA Khan BR Davidson R Goldin, et al. 2005 Guideline for the diagnosis and treatment of cholangiocarcinoma: consensus document Gut 51 S1 S9
10. PC de Groen GJ Gores NF LaRusso, et al. 1999 Biliary tract cancers N Engl J Med 341 1368 1378 10536130 10.1056/NEJM199910283411807 (Pubitemid 29503577)
11. H Bismuth MB Corlette 1975 Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver Surg Gynecol Obstet 140 170 176 1079096 1:STN:280:DyaE2M7ktFWiug%3D%3D
12. H Bismuth R Nakache T Diamond 1992 Management strategies in resection for hilars cholangiocarcinoma Ann Surg 215 31 38 1309988 10.1097/00000658- 199201000-00005 1:STN:280:DyaK387hslOnsg%3D%3D
13. MF Gerhards D den Hartog EA Rauws, et al. 2001 Palliative treatment in patients with unresectable hilar cholangiocarcinoma: results of endoscopic drainage in patients with type III and IV hilar cholangiocarcinoma Eur J Surg 167 274 280 11354319 10.1080/110241501300091444 1:STN:280:DC%2BD3M3lsF2jtw%3D%3D (Pubitemid 32336886)
14. V Válek P Kysela Z Kala, et al. 2007 Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study Eur J Radiol 62 175 179 17344008 10.1016/j.ejrad.2007.01.037 (Pubitemid 46578186)
15. WH Paik YS Park JH Hwang, et al. 2009 Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach Gastrointest Endosc 69 55 62 18657806 10.1016/j.gie.2008.04.005
16. GD De Palma A Pezzullo M Rega, et al. 2003 Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study Gastrointest Endosc 58 50 53 12838220 10.1067/mge.2003.310 (Pubitemid 38208746)
17. JL Cheng MJ Bruno JJ Bergman, et al. 2002 Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents Gastrointest Endosc 56 33 39 12085032 10.1067/mge.2002.125364 (Pubitemid 41115046)
18. WH Chang P Kortan GB Haber 1998 Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage Gastrointest Endosc 47 354 362 9609426 10.1016/S0016-5107(98)70218-4 1:STN:280:DyaK1c3ntVGruw%3D%3D (Pubitemid 28237504)
19. TH Baron 2008 Photodynamic therapy: standard of care for palliation of cholangiocarcinoma? Clin Gastroenterol Hepatol 6 266 267 18328433 10.1016/j.cgh.2008.01.015 (Pubitemid 351318386)
20. G Eisen 2010 A short note from the Editor-in-Chief: the next 5 years of GIE Gastrointest Endosc 71 10 10.1016/j.gie.2009.11.016
21. KF Schulz DG Altman D Moher 2010 for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 1 7
22. D Mohera S Hopewellb KF Schulz, et al. 2010 CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials J Clin Epidemiol 63 e1 e37 10.1016/j.jclinepi.2010.03.004
23. E Von Elm DG Altman M Egger, et al. 2007 The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Ann Intern Med 147 573 577 (Pubitemid 351664504)
24. JP Vandenbroucke E Von Elm DG Altman, et al. 2007 Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration Ann Intern Med 147 W163 W194 17938389
25. L Julian PTH Julian PAI John, et al. 2009 STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement Ann Intern Med 150 206 215
26. D Dolmans D Fukumura R Jain 2003 Photodynamic therapy for cancer Nat Rev Cancer 3 380 387 12724736 10.1038/nrc1071 1:CAS:528:DC%2BD3sXjtlals74%3D (Pubitemid 37328858)
27. Z Huang H Xu AD Meyers, et al. 2008 Photodynamic therapy for treatment of solid tumors-potential and technical challenges Technol Cancer Res Treat 7 309 320 18642969 1:CAS:528:DC%2BD1cXhtFSrtbbO
28. T Zoepf R Jakobs A Rosenbaum, et al. 2001 Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer Gastrointest Endosc 54 763 766 11726858 10.1067/mge.2001.119605 1:STN:280:DC%2BD3MnotVeqsQ%3D%3D (Pubitemid 33668686)
29. T Zoepf R Jakobs JC Arnold, et al. 2001 Photodynamic therapy for palliation of nonresectable bile duct cancer-preliminary results with a new diode laser system Am J Gastroenterol 96 2093 2097 11467637 1:STN:280: DC%2BD3MvhvFartA%3D%3D (Pubitemid 32660902)
30. A Rumalla TH Baron KK Wang, et al. 2001 Endoscopic application of photodynamic therapy for cholangiocarcinoma Gastrointest Endosc 53 500 504 11275896 10.1067/mge.2001.113386 1:STN:280:DC%2BD3M7oslShsw%3D%3D (Pubitemid 33586760)
31. GA Prasad KK Wang TH Baron, et al. 2007 Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma Clin Gastroenterol Hepatol 5 743 748 17545000 10.1016/j.cgh.2007.02.021 (Pubitemid 46830054)
32. LW Wang LB Li ZS Li, et al. 2008 Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible? Lasers Surg Med 40 651 659 18951422 10.1002/lsm.20680
33. ASGE technology assessment committee 2006 Photodynamic therapy for gastrointestinal disease GIE 7 927 932
34. JS McCaughan BF Mertens C Cho, et al. 1991 Photodynamic therapy to treat tumors of the extrahepatic biliary ducts A case report. Arch Surg 126 111 113
35. MA Ortner J Liebetruth S Schreiber, et al. 1998 Photodynamic therapy of nonresectable cholangiocarcinoma Gastroenterology 114 536 542 9496944 10.1016/S0016-5085(98)70537-2 1:STN:280:DyaK1c7ls1Kmug%3D%3D (Pubitemid 28141199)
36. F Berr M Wiedmann A Tannapfel, et al. 2000 Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival Hepatology 31 291 298 10655248 10.1002/hep.510310205 1:STN:280:DC%2BD3c7it1ehtw%3D%3D (Pubitemid 30078590)
37. GC Harewood TH Baron A Rumalla, et al. 2005 Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma J Gastroenterol Hepatol 20 415 420 15740486 10.1111/j.1440-1746.2005.03582.x (Pubitemid 40469343)
38. FL Dumoulin T Gerhardt S Fuchs, et al. 2003 Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma Gastrointest Endosc 57 860 867 12776033 10.1016/S0016-5107(03)70021-2 (Pubitemid 47231345)
39. M Wiedmann F Berr I Schiefke, et al. 2004 Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study Gastrointest Endosc 60 68 75 15229428 10.1016/S0016-5107(04)01288-X (Pubitemid 38833701)
40. D Fuks E Bartoli R Delcenserie, et al. 2009 Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice J Gastroenterol Hepatol 24 1745 1752 19780885 10.1111/j.1440-1746.2009. 05915.x 1:CAS:528:DC%2BD1MXhsFCktrnI
41. H Witzigmann F Berr U Ringel, et al. 2006 Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection Ann Surg 244 230 239 16858185 10.1097/01.sla.0000217639.10331.47 (Pubitemid 44305537)
42. CS Shim YK Cheon SW Cha, et al. 2005 Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment Endoscopy 37 425 433 15844020 10.1055/s-2005-861294 1:STN:280:DC%2BD2M3gvVOqtQ%3D%3D (Pubitemid 40668207)
43. ME Ortner K Caca F Berr, et al. 2003 Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study Gastroenterology 125 1355 1363 14598251 10.1016/j.gastro.2003.07.015 (Pubitemid 37409755)
44. ME Ortner G Dorta 2006 Technology insight: photodynamic therapy for cholangiocarcinoma Nat Clin Pract Gastroenterol Hepatol 3 459 467 16883350 10.1038/ncpgasthep0543 1:CAS:528:DC%2BD28Xos1GktL0%3D (Pubitemid 44203799)
45. T Zoepf R Jakobs JC Arnold, et al. 2005 Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy Am J Gastroenterol 100 2426 2430 16279895 10.1111/j.1572-0241.2005.00318.x 1:CAS:528: DC%2BD2MXht1OgsrfJ
46. M Kahaleh R Mishra VM Shami, et al. 2008 Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy Clin Gastroenterol Hepatol 6 290 297 18255347 10.1016/j.cgh.2007.12.004
47. A Nanashima H Yamaguchi S Shibasaki, et al. 2004 Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study J Gastroenterol 39 1095 1101 15580404 10.1007/s00535-004-1449-z (Pubitemid 39618794)
48. M Wiedmann K Caca F Berr, et al. 2003 Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study Cancer 97 2783 2790 12767091 10.1002/cncr.11401 (Pubitemid 36605146)